From Dr. Bredesen
Chief Science Officer
November 19, 2024•From Dr. Bredesen, News
How the LA Times Got it Backwards
The blog, How the LA Times Got It Backwards, explains why the recent op-ed encouraging all of us to avoid testing for Alzheimer’s (!) is misinformed, misguided, and could lead to dementia in many people needlessly. Early testing for chronic diseases such as diabetes, hypertension, cardiovascular disease, cervical cancer, and colorectal cancer has been our most potent weapon against these common and high-mortality diseases. As he points out, there are two new advances that, if we all availed ourselves of these, could make Alzheimer’s dementia a very rare condition. Read More »
October 22, 2024•From Dr. Bredesen, News
The Large and Growing Armamentarium
In The Large and Growing Armamentarium, Dr. Bredesen describes some of the many new methods we have to diagnose and track brain and overall health that better allow us to utilize new therapeutic methods that have become available and are contributing to improved outcomes in those with cognitive decline or risk for decline. For those who start early, with prevention or early intervention, the dementia of Alzheimer’s is now, for the first time, optional. Read More »
September 23, 2024•From Dr. Bredesen, News
In, A Holy Grail for ApoE4?, Dr. Bredesen describes a remarkable new drug candidate that appears to reduce the genetic risk of ApoE4. This potentially game-changing drug was born out of decades of work that began in Dr. Bredesen’s lab at the Buck Institute. Once it is eligible, he plans to make a strong case for compassionate use, given that no other medications have proven capable of sustainably improving cognition for this subgroup. Read More »
August 19, 2024•From Dr. Bredesen, News
Why Alzheimer’s Is Now Optional
In Dr. Bredesen's blog, Why Alzheimer's is Now Optional, he discusses how a direct-to-consumer blood test, that can track your Alzheimer's status and progress, has replaced expensive, high-radiation PET scans, and painful spinal taps to empower patients to take control over their cognitive destiny. A simple blood test has entirely changed the Alzheimer's landscape and puts the power directly in the hands of consumers. Read More »
July 24, 2024•From Dr. Bredesen, News
In Dr. Bredesen’s blog, he describes a study in which autism was reversed in twins, a result that some called a miracle. He discusses the implications for the treatment of other developmental disorders, and for the practice of 21st-century medicine. Read More »
June 14, 2024•From Dr. Bredesen, News
Dr. Bredesen writes about why reassurance, such an important part of the patient-physician interaction when used appropriately, is rapidly becoming one of his least favorite words. Patient after patient has been reassured that his or her cognitive complaints are simply normal aging, leading to delays in optimal treatment, sometimes with tragic consequences. Please do not allow these to delay your treatment. Read More »
May 16, 2024•From Dr. Bredesen, News
In his blog, False Hopelessness Yet Again, Dr. Bredesen cites a research study that claims that anyone who has two copies of the ApoE4 gene is predetermined to develop a distinct form of Alzheimer's. Dr. Bredesen explains that nothing could be further from the truth, citing the success of hundreds of case studies and his clinical trial — demonstrating that ApoE4 homozygotes can prevent and reverse cognitive decline. Read More »
April 17, 2024•From Dr. Bredesen, News
Outcomes or Incomes? Fact or Fiction Advertisement?
In his blog, Outcomes or Incomes? Fact or Fiction Advertisement?, Dr. Dale Bredesen compares the dangerous advertising campaigns of the past that promoted and provided disinformation about harmful chemicals, drugs, cigarettes, etc., claiming they benefitted your health, to the modern-day marketing campaigns that use the same tactics to entice and mislead customers. Read More »